The Vanguard Group, Inc. recently announced the acquisition of new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). The institutional investor has increased its shareholding in the Healthcare company by 1.51% to 24.22 million shares with purchase of 0.36 million shares. This fresh investment now brings its stake to 11.27% valued currently at $922.21 million. In addition, Artisan Partners LP raised its holdings by 0.35 million to 13.58 million shares. And Nuance Investments LLC has lifted its position by 0.74% or 92591.0 shares – to 12.64 million shares.
With over 3.38 million DENTSPLY SIRONA Inc. (XRAY) shares trading Monday and a closing price of $37.55 on the day, the dollar volume was approximately $126.88 million. The shares have shown a positive half year performance of 10.57% and its price on 03/13/23 gained nearly 1.68%. Currently, there are 215.20M common shares owned by the public and among those 213.66M shares have been available to trade.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 13 analysts who have offered their price forecasts for XRAY have a consensus price objective of $39.73. The analysts have set the share’s price value over the next 12 months at a high of $45.00 and a low of $36.00. The average price target is 5.89% above its recent price level and a downside to the estimated low will see the stock lose -4.31% over that period. But an upside of 16.56% will see the stock hit the forecast high price target while median target price for the stock is $39.00.
Insiders at the company have transacted a total of 100 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 86 of these insider trades were purchases, accounting for 1,058,314 shares. Insider sales of the common stock occurred on 14 occasions, with total insider shares sold totaling 127,538 shares.
The top 3 mutual fund holders in DENTSPLY SIRONA Inc. are First Eagle Global Fund, Nuance Mid Cap Value Fund, and Vanguard Total Stock Market Index. First Eagle Global Fund owns 6.9 million shares of the company’s stock, all valued at over $262.72 million. Nuance Mid Cap Value Fund bought 1.5 million shares to see its total holdings expand to 6.65 million shares valued at over $253.35 million and representing 3.10% of the shares outstanding. Vanguard Total Stock Market Index bought 34648.0 shares to bring its total holdings to over 6.58 million shares at a value of $250.69 million. Vanguard Total Stock Market Index now owns shares totaling to 3.06% of the shares outstanding.
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) opened at $36.57, down -$0.36 from a prior closing price of $36.93. However, the script later moved the day high at 38.37, up 1.68%. The company’s stock has a 5-day price change of -4.38% and 24.01% over the past three months. XRAY shares are trading 17.93% year to date (YTD), with the 12-month market performance down to -25.91% lower. It has a 12-month low price of $26.48 and touched a high of $51.15 over the same period. XRAY has an average intraday trading volume of 2.09 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.27%, 3.86%, and 10.77% respectively.
Institutional ownership of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) 215.20M shares outstanding. Mutual fund holders own 43.69%, while other institutional holders and individual stakeholders account for 62.13% and 1.96% respectively.
It has a market capitalization of $8.12B and a beta (3y monthly) value of 0.91. The earnings-per-share (ttm) stands at -$4.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.35% over the week and 2.97% over the month.
Analysts forecast that DENTSPLY SIRONA Inc. (XRAY) will achieve an EPS of $0.32 for the current quarter, $0.36 for the next quarter and $1.84 for 2023. The lowest estimate earnings-per-share for the quarter is $0.3 while analysts give the company a high EPS estimate of $0.35. Comparatively, EPS for the current quarter was $0.76 a year ago. Earnings per share for the fiscal year are expected to decrease by -336.20%, and 18.08% over the next financial year. EPS should shrink at an annualized rate of 3.90% over the next five years, compared to 7.90% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 13 brokerage firm advisors rate DENTSPLY SIRONA Inc. (XRAY) as a “Moderate Buy” at a consensus score of 2.60. Specifically, 5 Wall Street analysts polled rate the stock as a buy, while 8 of the 13 advise that investors “hold,” and 0 rated it as a “Sell.”
Piper Sandler on their part issued Neutral rating on April 20, 2022.
Leave a Reply